Xpert® MRSA/SA Blood Culture
Accurate detection of MRSA and SA in positive blood culture specimens in about an hour
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
product image
10 Tests
GXMRSA/SA-BC-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support

The Need

  • Bloodstream infections cause an estimated 250,000 deaths annually in North America and Europe combined1
  • S. aureus and MRSA continue to be leading causes of bloodstream infections and are associated with increased length of stay and hospital costs2
  • Current culture-based lab testing methods for gram-positive blood culture bottles require an additional 24–72 hours for determination of S. aureus or MRSA
  • Early antimicrobial treatment can reduce bloodstream infection mortality2
1 Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501–9.
Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA,
2 Parcel B, et al. Rapid molecular testing for Staphylococcus aureus bacteraemia improves clinical management. J Med Microbiol. 2020 Mar;.

The Solution

The Xpert MRSA/SA Blood Culture test is a qualitative in vitro diagnostic test designed for rapid and simultaneous detection of S. aureus and methicillin-resistant S. aureus (MRSA) directly from gram-positive blood cultures.
The Xpert MRSA/SA Blood Culture test delivers:
  • Efficient laboratories with on-demand workflows that require minimal hands-on time
  • Optimized therapy to support improved patient outcomes and reduced empirical prescribing

The Impact

  • Reduced result reporting turnaround time median of 24 hours, enabling earlier patient management review2
  • Optimized antimicrobial therapy 1.7 days sooner3
  • Reduced length-of-stay mean to 6.2 days3
2 Parcel B, et al. Rapid molecular testing for Staphylococcus aureus bacteraemia improves clinical management. J Med Microbiol. 2020 Mar;.
3 Goff D, et al. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureu sblood culture test in
patients with S. aureus bacteremia. Clin Infect Dis. 2010